Journal of Cellular and Molecular Pharmacology
Open Access

Cytotoxicity assays; Cell viability; Drug toxicity; Pharmacology; Toxicology; Drug development; Cell proliferation; Cell death; Assays

Introduction

Cytotoxicity assays are laboratory tests used to evaluate the toxic effects of substances on cells. These assays play a vital role in drug development, environmental toxicology, and the assessment of chemical safety. Understanding how a substance affects cellular health is fundamental for identifying potentially harmful compounds and ensuring the safety of new drugs before clinical application [1,2]. Cytotoxicity assays provide critical information regarding a compound’s potential to damage cells, induce cell death, or disrupt cellular functions, which can be linked to adverse effects such as organ toxicity, carcinogenicity, and teratogenicity.

In pharmacological and toxicological research, cytotoxicity testing is commonly performed to assess the viability of cells in the presence of a compound, drug, or environmental toxin. Different assays use various techniques to quantify cell viability, proliferation, or apoptosis (programmed cell death). Given the importance of these tests, this article will discuss the different types of cytotoxicity assays, their principles, applications, and limitations.

Principles of Cytotoxicity Assays

Cytotoxicity assays generally work by assessing cell viability, which is an indicator of a cell's ability to grow, survive, and divide. The degree of cytotoxicity is often determined by the extent of damage caused to the cells in response to a given substance [3]. Cytotoxicity can manifest in various ways, including:

Cell death: Toxic substances may cause cell death through necrosis (uncontrolled cell death) or apoptosis (programmed cell death). Both forms of death are assessed in cytotoxicity assays.

Cell proliferation: Some cytotoxic agents inhibit cell proliferation, which can be measured as a decrease in cell growth.

Cellular damage: Cytotoxic agents may also cause sub-lethal damage, which may not kill the cells but could affect their function, membrane integrity, or metabolic activity [4].

To measure these effects, various methods are employed to detect changes in cellular components, including enzymes, cell membranes, and genetic material.

Types of Cytotoxicity Assays:

MTT assay (Methylthiazolyldiphenyl-tetrazolium bromide): The MTT assay is one of the most widely used tests to measure cell viability and cytotoxicity. It is based on the ability of living cells to reduce MTT, a yellow substrate, to a purple formazan product [5]. The amount of formazan formed correlates with the number of viable cells. This assay is simple, cost-effective, and suitable for high-throughput screening, making it ideal for evaluating drug toxicity.

Trypan blue exclusion test: The trypan blue assay is based on the principle that live cells possess intact cell membranes that exclude the dye, while dead cells take up the blue dye. The percentage of dead cells is calculated by counting the number of stained cells under a microscope. This assay is widely used for determining cell viability and assessing acute toxicity [6].

Lactate dehydrogenase (LDH) release assay: The LDH assay detects the release of lactate dehydrogenase from damaged cells. When cells are injured, LDH is released into the extracellular medium. By measuring the enzyme’s activity in the culture medium, researchers can quantify the extent of cell damage or death. This method is commonly used for assessing cytotoxicity caused by chemicals, drugs, or physical stress.

Flow cytometry-based assays: Flow cytometry is a powerful technique used to assess various aspects of cell health, including apoptosis, necrosis, and cell cycle progression. By using fluorescent markers that label specific cellular components, such as DNA or phosphatidylserine (a marker for apoptosis), flow cytometry allows for detailed analysis of cytotoxicity at the single-cell level [7]. This method is highly sensitive and can provide data on both cell viability and the mechanism of cell death.

Neutral red uptake assay: In this assay, living cells are able to incorporate the neutral red dye into lysosomes, while dead cells cannot. The intensity of the color is proportional to the number of viable cells, making it a useful method for assessing cell viability and cytotoxicity.

Annexin V/Propidium Iodide (PI) staining: Annexin V binds to phosphatidylserine, which is externalized on the surface of cells undergoing apoptosis. Propidium iodide, a DNA-binding dye, stains dead or necrotic cells with compromised membranes. By using flow cytometry, researchers can distinguish between viable, apoptotic, and necrotic cells, providing insight into the mechanism of cytotoxicity.

Applications of Cytotoxicity Assays

Drug development and screening: Cytotoxicity assays are widely used in preclinical drug development to evaluate the safety profile of new compounds [8]. By testing various concentrations of drugs on cultured cells, researchers can identify toxic doses and assess the therapeutic window for potential drugs. These assays help identify candidates for further development and clinical trials.

Cancer research: Cytotoxicity assays are essential for evaluating the effectiveness of anticancer agents. These assays can help determine how cancer cells respond to chemotherapy, targeted therapies, and immunotherapies. Furthermore, they can be used to assess the ability of novel compounds to induce apoptosis in cancer cells.

Environmental toxicology: Cytotoxicity assays are used to assess the toxic effects of environmental chemicals, pollutants, and pesticides on cells. By evaluating the cellular response to these agents, researchers can predict the potential impact on human health and the environment.

Toxicology and safety testing: The pharmaceutical, cosmetic, and chemical industries rely on cytotoxicity assays to test the safety of new compounds before they are approved for use in humans [9]. Regulatory agencies such as the FDA and European Medicines Agency (EMA) require cytotoxicity data as part of the approval process for new drugs and chemicals.

Limitations of Cytotoxicity Assays

Cell line specificity: Most cytotoxicity assays are conducted using immortalized cell lines that may not fully represent the behavior of primary human cells. As a result, the results may not always accurately predict in vivo toxicity.

Lack of predictive power for complex toxicities: While cytotoxicity assays can identify cell death and damage, they may not predict long-term toxic effects such as organ-specific damage, developmental toxicity, or carcinogenicity [10].

Over-simplification of cellular systems: Many cytotoxicity assays use cultured cells in a controlled laboratory setting, which may not replicate the complexity of a whole organism. Assays may fail to account for factors like drug absorption, distribution, metabolism, and excretion.

Conclusion

Cytotoxicity assays are indispensable tools for assessing the safety and efficacy of new drugs, chemicals, and environmental agents. They provide valuable insights into cellular responses to toxins and help ensure that compounds undergo thorough safety evaluations before human exposure. By offering an understanding of how a substance affects cell viability, proliferation, and death, cytotoxicity assays play a key role in drug development, cancer research, and environmental toxicology. However, it is important to recognize the limitations of these assays and complement them with additional in vivo models and long-term safety testing to gain a comprehensive understanding of a compound's toxicity profile.

1. Baell JB,Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem: 2719-2740.

Indexed at, Google Scholar, Crossref

2. Bajorath J, Peltason L, Wawer M (2009) Navigating structure-activity landscapes. Drug Discov Today 14: 698-705.

Indexed at, Google Scholar, Crossref

3.  Berry M, Fielding BC, Gamieldien J (2015) Potential broad Spectrum inhibitors of the coronavirus 3CLpro a virtual screening and structure-based drug design. Study Viruses 7: 6642-6660.

Indexed at, Google Scholar, Crossref

4.  Capuzzi SJ, Muratov EN, Phantom TA (2017) Problems with the Utility of Alerts for Pan-Assay INterference Compound. J Chem Inf Model 57: 417-427.

Indexed at, Google Scholar, Crossref

5. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 57: 417-427.

Indexed at, Google Scholar, Crossref

6. Dong E, Du EL, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time Lancet. Infect Dis 7: 6642-6660.

Indexed at, Google Scholar, Crossref

7.  Fan HH, Wang LQ (2020) Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus. Model Chin Med J.

Indexed at, Google Scholar, Crossref

8. Gao J, Tian Z, Yan X (2020) Breakthrough Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14: 72-73.

Indexed at, Google Scholar, Crossref

9. Flexner C (1998) HIV-protease inhibitors N Engl J Med 338: 1281-1292.

Indexed at, Google Scholar, Crossref

10. Ghosh AK, Osswald HL (2016) Prato Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV/AIDS. J Med Chem 59: 5172-5208.

Indexed at, Google Scholar, Crossref